Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · IEX Real-Time Price · USD
0.629
-0.004 (-0.63%)
Jul 22, 2024, 10:04 AM EDT - Market open
Bluejay Diagnostics Employees
Bluejay Diagnostics had 10 employees as of December 31, 2023. The number of employees decreased by 6 or -37.50% compared to the previous year.
Employees
10
Change (1Y)
-6
Growth (1Y)
-37.50%
Revenue / Employee
n/a
Profits / Employee
-$974,251
Market Cap
359.19K
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10 | -6 | -37.50% |
Dec 31, 2022 | 16 | 7 | 77.78% |
Dec 31, 2021 | 9 | - | - |
Related Stocks
Company Name | Employees |
---|---|
China SXT Pharmaceuticals | 78 |
Biodexa Pharmaceuticals | 21 |
Dermata Therapeutics | 8 |
GRI Bio | 4 |
Bone Biologics | 2 |
Salarius Pharmaceuticals | 2 |
BJDX News
- 23 days ago - Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering - GlobeNewsWire
- 26 days ago - SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) - GlobeNewsWire
- 9 months ago - Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results - GlobeNewsWire
- 11 months ago - Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - GlobeNewsWire
- 1 year ago - Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results - GlobeNewsWire